Publication | Closed Access

Glucagon-like peptide-1 is associated with poor clinical outcome, lipopolysaccharide translocation and inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass

InflammationGastrointestinal Peptide HormoneCardiothoracic SurgeryCardiovascular DiseaseDisease PathophysiologyLipopolysaccharide TranslocationPoor Clinical OutcomeImmunologyGlucagon-like Peptide-1MedicineCardiologyAnesthesiologyCardiovascular Translational Research